UBIDECARENONE: 361 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
Route: ORAL · Manufacturer: Energique, Inc. · HUMAN OTC DRUG · FDA Label: Available
First Report: 1999 · Latest Report: 20250323
What Are the Most Common UBIDECARENONE Side Effects?
All UBIDECARENONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 130 | 36.0% | 1 | 108 |
| Headache | 125 | 34.6% | 0 | 106 |
| Pain | 125 | 34.6% | 0 | 108 |
| Malaise | 115 | 31.9% | 0 | 107 |
| Off label use | 114 | 31.6% | 0 | 102 |
| Nausea | 113 | 31.3% | 0 | 104 |
| Therapeutic product effect incomplete | 113 | 31.3% | 0 | 105 |
| Abdominal pain | 109 | 30.2% | 0 | 107 |
| Constipation | 109 | 30.2% | 0 | 105 |
| Pyrexia | 109 | 30.2% | 0 | 107 |
| Weight decreased | 107 | 29.6% | 0 | 105 |
| Anaemia | 106 | 29.4% | 0 | 105 |
| Infusion related reaction | 106 | 29.4% | 0 | 105 |
| Chronic sinusitis | 105 | 29.1% | 0 | 105 |
| Colitis | 105 | 29.1% | 0 | 105 |
| Erythema | 105 | 29.1% | 0 | 104 |
| Female genital tract fistula | 104 | 28.8% | 0 | 104 |
| Frequent bowel movements | 104 | 28.8% | 0 | 103 |
| Haematochezia | 104 | 28.8% | 0 | 104 |
| Macular degeneration | 104 | 28.8% | 0 | 104 |
Who Reports UBIDECARENONE Side Effects? Age & Gender Data
Gender: 82.6% female, 17.4% male. Average age: 60.7 years. Most reports from: CA. View detailed demographics →
Is UBIDECARENONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 0 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 0 |
| 2011 | 3 | 0 | 0 |
| 2012 | 4 | 0 | 0 |
| 2013 | 2 | 0 | 1 |
| 2014 | 10 | 0 | 2 |
| 2015 | 17 | 1 | 5 |
| 2016 | 11 | 0 | 6 |
| 2017 | 8 | 0 | 1 |
| 2018 | 13 | 0 | 9 |
| 2019 | 11 | 1 | 7 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 0 |
What Is UBIDECARENONE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 220 |
| Cardiac disorder | 5 |
| Hypercholesterolaemia | 5 |
| Supplementation therapy | 5 |
UBIDECARENONE vs Alternatives: Which Is Safer?
Official FDA Label for UBIDECARENONE
Official prescribing information from the FDA-approved drug label.
FDA Approved Uses (Indications)
USES: May temporarily relieve poor memory.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS:
- Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional.
- Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: Stop use and ask a doctor if symptoms persist for more than 7 days. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. DO NOT USE IF TAMPER EVIDENT SEAL IS BROKEN OR MISSING Store in a cool, dry place.
Active Ingredient
ACTIVE INGREDIENT: (in each drop): Ubidecarenonum 30X 100%.
Inactive Ingredients
INACTIVE INGREDIENTS: Demineralized water, 20% Ethanol.